SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is drawing significant investor attention due to recent conservative 2026 revenue guidance and uncertainty surrounding DefenCath's post-TDAPA reimbursement, fueling widespread frustration despite a new $75 million share repurchase program. The community is actively discussing potential legislative fixes and upcoming pipeline catalysts like Rezzayo's Phase 3 data, while scrutinizing management's actions amid the stock's pronounced decline.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending amidst a high-stakes bidding war for Warner Bros. Discovery, intensified by a widening DOJ antitrust probe and political threats; the community is actively debating whether walking away with a breakup fee or proceeding with the acquisition would be a better outcome for the streaming giant.

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.

Astrazeneca plc

AstraZeneca PLC

AstraZeneca is trending as a leader in pharmaceutical innovation, driven by multiple recent FDA priority reviews for pivotal breast cancer and hypertension therapies, alongside strategic advancements in its obesity drug pipeline. The community is actively discussing the company's robust long-term growth projections and global market expansion efforts, further amplified by its recent NYSE listing.

Strive, Inc. engages in the provision of an asset management Bitcoin treasury. It is focused on maximizing value for shareholders, accumulating bitcoin and outperforming bitcoin over the long run. The company was founded by Arshia Sarkhani, Jackson Fairbanks, Arman Sarkhani, and Kyle Fairbanks on March 9, 2022 and is headquartered in Dallas, TX.

Strive Inc. - VR PRF PERPETUAL USD 100 - Ser A

Strive Inc

SATA is trending as it trades around a key price threshold, allowing its parent company, Strive Inc. ($ASST), to raise non-dilutive capital for Bitcoin acquisitions and debt repayment. Investors are keenly interested in its high dividend yield and its strategic role as a preferred stock for amplified Bitcoin treasury exposure.

Progressive Corp. is an insurance holding company, which engages in the provision of personal and commercial auto insurance, residential property insurance, and other specialty property-casualty insurance and related services. It operates through the following segments: Personal Lines, Commercial Lines, and Property. The Personal Lines segment includes agency and direct businesses. The Commercial Lines segment writes primary liability and physical damage insurance for automobiles and trucks owned and operated predominately by small business in the auto, for-hire transportation, contractor, for-hire specialty, tow, and for-hire livery markets. The Property segment covers residential property insurance for homeowners, other property owners, and renters. The company was founded on March 10, 1937, and is headquartered in Mayfield Village, OH.

Progressive Corp.

Progressive Corp

Progressive is a trending topic amidst mixed reactions to its recent financial reports, which show strong premium and investment income growth alongside fluctuating combined ratios, prompting widespread customer discussion around rising rates. The community is actively debating if its valuation is justified by its tech-driven underwriting and potential AI leadership, or if customer dissatisfaction and market dynamics present challenges within the insurance sector.

Polygon

Polygon (POL) is trending as its strategic pivot to become a foundational layer for regulated payments and Real-World Assets (RWAs) gains traction, highlighted by recent acquisitions and soaring on-chain payment volumes. The community is actively discussing its perceived undervaluation and anticipating a significant rally given its growing utility and deflationary tokenomics.

Yelp, Inc. engages in the provision of business of operating a community-driven platform that connects people with great local businesses. The company was founded by Jeremy Stoppelman and Russell Simmons in July 2004 and is headquartered in San Francisco, CA.

Yelp Inc

Yelp (YELP) is trending as recent earnings guidance and the substantial acquisition of an AI lead management platform, Hatch, fuel debate, alongside its ongoing antitrust lawsuit against Google. The community is sharply divided, with critics highlighting concerns over employee compensation and intense competition, while proponents emphasize strong cash flow, share repurchases, and strategic AI integrations.

Ankr is a Web3 decentralized infrastructure provider that helps developers, dapps, and stakers easily interact with multiple blockchains. It allows you to create DApps using API and RPC, staking on Ankr Earn, and use customized blockchain solutions for businesses.

Ankr Network

ANKR is trending amidst intense community debate, largely driven by widespread frustration and accusations of it being a 'scam' due to its continued underperformance compared to other cryptocurrencies. Despite this, some holders remain optimistic, pointing to its foundational Web3 infrastructure and upcoming Neura L1 as long-term value drivers.

Caledonia Mining Corp. Plc engages in the exploration, development, and production of gold and other precious metals from its mineral properties. Its projects include Blanket Gold Mine and Maligreen. The company was founded on February 5, 1992 and is headquartered in St. Helier, the United Kingdom.

Caledonia Mining Corporation Plc

Caledonia Mining is trending due to surging gold prices and recent positive geopolitical developments in Zimbabwe, including eased sanctions and a more favorable royalty structure. Despite these tailwinds, the community is actively discussing the company's perceived undervaluation, especially considering the significant production growth potential from its Bilboes project, which is being advanced through a recently priced convertible note offering.

Oasis is a layer-one blockchain built to support confidential applications at scale. It’s home to Sapphire, the world’s first private EVM network, Oasis Privacy Layer, a cross-chain privacy solution for any EVM dApp, and Runtime Offchain Logic, a framework that brings trustworthy off-chain computing, onchain. Powered by its ROSE token, Oasis leverages a unique layered architecture and native rollup support, making it ideal for use cases in AI, DeFi, DAOs, gaming, and more.

Oasis Network

Oasis Network (ROSE) is trending due to its notable resilience during a recent crypto market dip, sparking investor interest in its privacy-first blockchain technology. The community is actively discussing its significant advancements in confidential AI and its perceived undervaluation as a key player in the evolving AI-crypto landscape.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Readystate Asset Management LP Boosts Stock Holdings in Janux Therapeutics, Inc. $JANX

Readystate Asset Management LP lifted its position in Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 38.0% in the 3rd quarter, according to the company in its most recent 13F filing with the...

Janux Therapeutics Announces First Patient Dosed in Phase 1 Study of JANX011

Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies, today announced that the first participant has been...

Janux Therapeutics (NASDAQ:JANX) Sets New 52-Week Low - Should You Sell?

Janux Therapeutics (NASDAQ:JANX) Hits New 52-Week Low - Time to Sell...

Wall Street Analysts See a 319.23% Upside in Janux Therapeutics (JANX): Can the Stock Really Move This High?

The average of price targets set by Wall Street analysts indicates a potential upside of 319.2% in Janux Therapeutics (JANX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Janux Therapeutics, Inc. (NASDAQ:JANX) Given Consensus Rating of "Moderate Buy" by Brokerages

Shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the fifteen research firms that are currently covering the stock...

Janux Therapeutics (NASDAQ:JANX) Shares Gap Down - Should You Sell?

Janux Therapeutics (NASDAQ:JANX) Shares Gap Down - Here's Why...

Janux Therapeutics Appoints William Go, M.D., Ph.D., as Chief Medical Officer

Janux Therapeutics, Inc., a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies based on its proprietary Tumor Activated T Cell Engager (TRACTr), Tumor...

JANX Enters Global Oncology Collaboration With BMY, Stock Rises

Janux Therapeutics struck a global licensing deal for its tumor-activated platforms, sending shares higher and expanding its reach in solid tumors.

Janux Therapeutics (NASDAQ:JANX) Sees Strong Trading Volume - Here's Why

Janux Therapeutics (NASDAQ:JANX) Sees Unusually-High Trading Volume - Still a Buy...

Janux Therapeutics Strikes Bristol Myers Biotech Deal Worth $800 Million

Janux Therapeutics signs a global licensing deal with Bristol Myers Squibb worth up to $800 million.read more...

Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded by David Campbell in June 2017 and is headquartered in San Diego, CA.

JANX
Janux Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest JANX News

JANXJanux Therapeutics Inc